Alexian Brothers Hospital in Illinois, is proudly reporting the availability of a new minimally invasive option for osteoarthritis sufferers. The OrthoGlide™ medial knee implant by Advanced Bio-Surfaces Inc., a spin-off of University of Minnesota, is an option for patients who have exhausted non-surgical therapies, and are not in need of total or partial knee replacement.
From the company, about their device that has been approved by the FDA:
The OrthoGlide implant is a device used for patients who have exhausted all other conventional therapies and yet are not ready for a more invasive total knee replacement (TKR). The OrthoGlide is a metallic medial hemiarthroplasty implant used to reduce pain and discomfort, and to correct angular abnormalities in patients with osteoarthritis of the medial compartment of the knee. The smooth glide path, and fixation by the posterior lip provide a low friction, stable implant that can be implanted by a minimally invasive technique. Our system also includes a kit of patented accessories used to optimize proper fitting of the OrthoGlide implant during the surgical procedure.